Tactical Therapeutics, Inc.   Report issue

For profit Phase 1
Founded: New York NY United States (2005)
Status: Left NME R&D (2018)

Organization Overview

First Clinical Trial
2010
NCT01107522
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now